Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Bertolini

Showing results (41-50 of 187) with videos related to

Pageof 19
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|August 15, 2012
Evaluation of circulating endothelial precursor cells in cancer patientsFrancesco Bertolini, Patrizia Mancuso, Liat Benayoun, et al.
Plastic and Reconstructive Surgery|May 25, 2017
Fat Grafting after Invasive Breast Cancer: A Matched Case-Control StudyJean Yves Petit, Patrick Maisonneuve, Nicole Rotmensz, et al.
BJU International|December 12, 2007
Circulating endothelial cells as a therapeutic marker for thalidomide in combined therapy with chemotherapy drugs in a human prostate cancer modelHaiqing Li, Valentina Raia, Francesco Bertolini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2006
On the origin and nature of elevated levels of circulating endothelial cells after treatment with a vascular disrupting agentYuval Shaked, Francesco Bertolini, Urban Emmenegger, et al.
British Journal of Cancer|April 27, 2018
Vinorelbine, cyclophosphamide and 5-FU effects on the circulating and intratumoural landscape of immune cells improve anti-PD-L1 efficacy in preclinical models of breast cancer and lymphomaStefania Orecchioni, Giovanna Talarico, Valentina Labanca, et al.
BMC Cancer|November 26, 2010
If it is in the marrow, is it also in the blood? An analysis of 1,000 paired samples from patients with B-cell non-Hodgkin lymphomaPatrizia Mancuso, Angelica Calleri, Pierluigi Antoniotti, et al.
Experimental Diabetes Research|April 5, 2012
Amelioration of glucose control mobilizes circulating pericyte progenitor cells in type 2 diabetic patients with microangiopathyGian Paolo Fadini, Patrizia Mancuso, Francesco Bertolini, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|November 11, 2005
SP4, a novel anti-cyclin D1 rabbit monoclonal antibody, is a highly sensitive probe for identifying mantle cell lymphomas bearing the t(11;14)(q13;q32) translocationGiancarlo Pruneri, Stefano Valentini, Francesco Bertolini, et al.
Breast (Edinburgh, Scotland)|October 4, 2005
Anti-angiogenic treatment of breast cancer using metronomic low-dose chemotherapyRaquel Munoz, Yuval Shaked, Francesco Bertolini, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 7, 2025
From combination early detection to multicancer testing: shifting cancer care toward proactive prevention and interceptionAdriana Albini, Dario Trapani, Francesco Bertolini, et al.
Pageof 19

Showing results (41-50 of 187) with videos related to

Sort By:
Pageof 19
Methods in Molecular Biology (Clifton, N.J.)|August 15, 2012
Evaluation of circulating endothelial precursor cells in cancer patientsFrancesco Bertolini, Patrizia Mancuso, Liat Benayoun, et al.
Plastic and Reconstructive Surgery|May 25, 2017
Fat Grafting after Invasive Breast Cancer: A Matched Case-Control StudyJean Yves Petit, Patrick Maisonneuve, Nicole Rotmensz, et al.
BJU International|December 12, 2007
Circulating endothelial cells as a therapeutic marker for thalidomide in combined therapy with chemotherapy drugs in a human prostate cancer modelHaiqing Li, Valentina Raia, Francesco Bertolini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2006
On the origin and nature of elevated levels of circulating endothelial cells after treatment with a vascular disrupting agentYuval Shaked, Francesco Bertolini, Urban Emmenegger, et al.
British Journal of Cancer|April 27, 2018
Vinorelbine, cyclophosphamide and 5-FU effects on the circulating and intratumoural landscape of immune cells improve anti-PD-L1 efficacy in preclinical models of breast cancer and lymphomaStefania Orecchioni, Giovanna Talarico, Valentina Labanca, et al.
BMC Cancer|November 26, 2010
If it is in the marrow, is it also in the blood? An analysis of 1,000 paired samples from patients with B-cell non-Hodgkin lymphomaPatrizia Mancuso, Angelica Calleri, Pierluigi Antoniotti, et al.
Experimental Diabetes Research|April 5, 2012
Amelioration of glucose control mobilizes circulating pericyte progenitor cells in type 2 diabetic patients with microangiopathyGian Paolo Fadini, Patrizia Mancuso, Francesco Bertolini, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|November 11, 2005
SP4, a novel anti-cyclin D1 rabbit monoclonal antibody, is a highly sensitive probe for identifying mantle cell lymphomas bearing the t(11;14)(q13;q32) translocationGiancarlo Pruneri, Stefano Valentini, Francesco Bertolini, et al.
Breast (Edinburgh, Scotland)|October 4, 2005
Anti-angiogenic treatment of breast cancer using metronomic low-dose chemotherapyRaquel Munoz, Yuval Shaked, Francesco Bertolini, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 7, 2025
From combination early detection to multicancer testing: shifting cancer care toward proactive prevention and interceptionAdriana Albini, Dario Trapani, Francesco Bertolini, et al.
Pageof 19